Drug Manufacturers
Revised, more industry-friendly PLI scheme for bulk drugs on the cards
As domestic sales decline, drug makers focus on exports to sustain growth
CVS raises profit forecast, in talks with US to administer Covid vaccines
Govt notifies incentive scheme for local API manufacturing to cut imports
Cipla to price Covid-19 drug remdesivir at less than Rs 5,000 per vial

Pvt players must help set up bulk drug, med devices pak: Mandaviya
Glenmark Pharma gets nod to launch favipiravir for Covid-19 patients
Lupin recieves USFDA nod to market generic anthelmintic tablets
Revised Wockhardt deal boosts prospects of Dr Reddy's India business
Joint inflammation drug may be repurposed to treat Covid-19: EMBO Study

Chennai-based start-up developing Covid-19 remedy, plans to test in US
AstraZeneca, Gilead merger likely to hit political, strategic hurdles
Remdesivir pricing in India likely to be lower than global rate: Sources
Dr Reddy's Q4 PBT up 22% at Rs 714 cr on buoyant US, European business
Antiviral drugs see demand surge in India, but segment declines 5.5%
Coronavirus: UP govt reopens 5,200 industrial units during lockdown
Coronavirus outbreak: Pharma market grows 9% in March due to panic buying
Coronavirus: ITC repurposes Himachal perfume plant to produce sanitisers
Govt allows doorstep delivery of drugs to help citizens under lockdown
Govt approves Rs 13K-crore package to boost bulk drugs manufacture